{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:10:51Z","timestamp":1780416651547,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["75N95023D00001"],"award-info":[{"award-number":["75N95023D00001"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["NCATS-P00438-B"],"award-info":[{"award-number":["NCATS-P00438-B"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.msard.2025.106944","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T16:23:38Z","timestamp":1766507018000},"page":"106944","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Neurological sequela of COVID-19 in adults with multiple sclerosis"],"prefix":"10.1016","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7231-7950","authenticated-orcid":false,"given":"Anjali","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Cherian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabiha","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5689-0044","authenticated-orcid":false,"given":"Michelle H.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2025.106944_bib0001","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jocn.2020.05.017","article-title":"Neurological manifestations and complications of COVID-19: a literature review","volume":"77","author":"Ahmad","year":"2020","journal-title":"J. Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.msard.2025.106944_bib0002","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10072-021-05612-5","article-title":"Depression, anxiety, and fear of COVID-19 in patients with multiple sclerosis in pandemic era: a cross-sectional study","volume":"43","author":"Alirezaei","year":"2022","journal-title":"Neurol. Sci."},{"issue":"1","key":"10.1016\/j.msard.2025.106944_bib0003","first-page":"2022","article-title":"Association of disease-modifying therapies with COVID-19 susceptibility and severity in patients with Multiple sclerosis: a systematic review and network meta-analysis","author":"Barzegar","year":"2022","journal-title":"Mult. Scler. Int."},{"key":"10.1016\/j.msard.2025.106944_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104947","article-title":"Multiple sclerosis is associated with worse COVID-19 outcomes compared to the general population: a population-based study","volume":"79","author":"Barzegar","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.msard.2025.106944_bib0005","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc. B."},{"issue":"5","key":"10.1016\/j.msard.2025.106944_bib0006","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chronic. Dis."},{"issue":"5","key":"10.1016\/j.msard.2025.106944_bib0007","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.12131","article-title":"Global incidence of neurological manifestations among patients hospitalized with COVID-19\u2014A report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium","volume":"4","author":"Chou","year":"2021","journal-title":"JAMA Netw. Open."},{"key":"10.1016\/j.msard.2025.106944_bib0008","author":"Collaborative"},{"key":"10.1016\/j.msard.2025.106944_bib0009","article-title":"COVID-19: neurologic complications and management of neurologic conditions","author":"Cucchiara","year":"2024","journal-title":"UpToDate"},{"issue":"5","key":"10.1016\/j.msard.2025.106944_bib0010","doi-asserted-by":"crossref","DOI":"10.3390\/cells12050684","article-title":"COVID-19 and Multiple sclerosis: a complex relationship possibly aggravated by low vitamin D levels","volume":"12","author":"Fernandes de Souza","year":"2023","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.msard.2025.106944_bib0011","article-title":"Recovery from COVID-19 in Multiple sclerosis: a prospective and longitudinal cohort study of the United Kingdom Multiple sclerosis register","volume":"9","author":"Garjani","year":"2021","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.msard.2025.106944_bib0012","first-page":"1","article-title":"Multiple sclerosis: pathogenesis, symptoms, diagnoses and cell-based therapy","volume":"19","author":"Ghasemi","year":"2017","journal-title":"Cell J."},{"issue":"3","key":"10.1016\/j.msard.2025.106944_bib0013","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/jamia\/ocaa196","article-title":"The National COVID Cohort Collaborative (N3C): rationale, design, infrastructure, and deployment","volume":"28","author":"Haendel","year":"2020","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"10.1016\/j.msard.2025.106944_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2023.1125109","article-title":"Alteration of the blood-brain barrier by COVID-19 and its implication in the permeation of drugs into the brain","volume":"17","author":"Hern\u00e1ndez-Parra","year":"2023","journal-title":"Front. Cell Neurosci."},{"issue":"6","key":"10.1016\/j.msard.2025.106944_bib0015","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1007\/s00415-020-09950-w","article-title":"A review of pathophysiology and neuropsychiatric manifestations of COVID-19","volume":"268","author":"Jasti","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2025.106944_bib0016","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a029025","article-title":"Effector T cells in multiple sclerosis","author":"Kaskow","year":"2018","journal-title":"Cold. Spring. Harb. Perspect. Med."},{"key":"10.1016\/j.msard.2025.106944_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103368","article-title":"Can COVID-19 exacerbate multiple sclerosis symptoms? A case series analysis","volume":"57","author":"Michelena","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106944_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.580507","article-title":"The psychological impact of COVID-19 Pandemic on people with multiple sclerosis","volume":"11","author":"Motolese","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2025.106944_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103180","article-title":"The comparison of fatigue, sleep quality, physical activity, quality of life, and psychological status in multiple sclerosis patients with or without COVID-19","volume":"55","author":"Ozkeskin","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106944_bib0020","unstructured":"Patient Health Questionnaire (PHQ-9). (1999). In: Pfizer Inc."},{"issue":"7","key":"10.1016\/j.msard.2025.106944_bib0021","first-page":"E532","article-title":"Identifying who has long COVID in the USA: a machine learning approach using N3C data","volume":"4","author":"Pfaff","year":"2022","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.msard.2025.106944_bib0022","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40263-021-00804-1","article-title":"COVID-19 in patients with multiple sclerosis: associations with disease-modifying therapies","volume":"35","author":"Reder","year":"2021","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.msard.2025.106944_bib0023","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1017\/cjn.2020.173","article-title":"Neurological and neuropsychiatric impacts of COVID-19 Pandemic","volume":"48","author":"Roy","year":"2021","journal-title":"Can. J. Neurol. Sci. J. Can. Sci. Neurol."},{"issue":"6","key":"10.1016\/j.msard.2025.106944_bib0024","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1001\/jamaneurol.2021.0688","article-title":"Outcomes and risk factors associated with SARS-CoV-2 infection in a North American registry of patients with multiple sclerosis","volume":"78","author":"Salter","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.msard.2025.106944_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102800","article-title":"COVID-19 and disease-modifying therapies in patients with demyelinating diseases of the central nervous system: a systematic review","volume":"50","author":"Sharifian-Dorche","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"5","key":"10.1016\/j.msard.2025.106944_bib0026","first-page":"416","article-title":"6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records","volume":"8","author":"Taquet","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.msard.2025.106944_bib0027","first-page":"11","article-title":"Psychological symptoms in COVID-19 patients: insights into pathophysiology and risk factors of long COVID-19","author":"Thye","year":"2022","journal-title":"Biology"},{"key":"10.1016\/j.msard.2025.106944_bib0029","doi-asserted-by":"crossref","DOI":"10.1177\/2040622320976979","article-title":"The neurological symptoms of COVID-19: a systematic overview of systematic reviews, comparison with other neurological conditions and implications for healthcare services","volume":"12","author":"Wildwing","year":"2021","journal-title":"Ther. Adv. Chronic. Dis."},{"key":"10.1016\/j.msard.2025.106944_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108427","article-title":"COVID-19 pathophysiology: a review","volume":"215","author":"Yuki","year":"2020","journal-title":"Clin. Immunol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825006820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825006820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T15:52:32Z","timestamp":1780415552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825006820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":29,"alternative-id":["S2211034825006820"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106944","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurological sequela of COVID-19 in adults with multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106944","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106944"}}